Proposed pathogenesis for atypical femoral fractures: Lessons from materials research

被引:105
作者
Ettinger, B. [1 ]
Burr, D. B. [2 ]
Ritchie, R. O. [3 ,4 ,5 ]
机构
[1] Univ Calif San Francisco, Med Ctr, Dept Med, San Francisco, CA 94111 USA
[2] Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA
[3] Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA
[4] Univ Calif Berkeley, Dept Mech Engn, Berkeley, CA 94720 USA
[5] Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA USA
关键词
Atypical femoral fractures; Bisphosphonates; Bone turnover; Aging; Bone quality; Bone biomechanics; SUPPRESSED BONE TURNOVER; NONENZYMATIC GLYCATION; POSTMENOPAUSAL WOMEN; MICRODAMAGE ACCUMULATION; BISPHOSPHONATE TREATMENT; MINERAL DENSITY; CORTICAL BONE; ALENDRONATE; RISEDRONATE; TOUGHNESS;
D O I
10.1016/j.bone.2013.02.004
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Atypical femoral fractures (AFFs) have been well defined clinically and epidemiologically. Less clear are the underlying mechanisms responsible. This commentary points out the likely sources of decreased resistance to fracture using lessons from bone material studies and biomechanics. We hypothesize that the key element in the cascade of events leading to failure of the largest and strongest bone in the human body is long-term suppression of normal bone turnover caused by exposure to potent anti-remodeling agents, most notably the bisphosphonates (BPs). Suppressed bone turnover produces changes in bone that alter its material quality and these changes could lead to adverse effects on its mechanical function. At the submicroscopic [<1 mu m] level of collagen fibrils, suppression of bone turnover allows continued addition of non-enzymatic cross links that can reduce collagen's plasticity and this in turn contributes to reduced bone toughness. Further, adverse changes in hydroxyapatite crystalline structure and composition can occur, perhaps increasing collagen's brittleness. At the microscopic level [similar to 1-500 mu m] of the bone-matrix structure, suppressed bone turnover allows full mineralization of cortical bone osteons and results in a microstructure of bone that is more homogeneous. Both brittleness and loss of heterogeneity allow greater progression of microscopic cracks that can occur with usual physical activity; in crack mechanical terms, normal mechanisms that dissipate crack tip growth energy are greatly reduced and crack progression is less impeded. Further, the targeted repair of cracks by newly activated BMUs appears to be preferentially suppressed by BPs. We further hypothesize that it is not necessary to have accumulation of many cracks to produce an AFF, just one that progresses - one that is not stopped by bone's several protective mechanisms and is allowed to penetrate through a homogeneous environment. The remarkable straight transverse fracture line is an indicator of the slow progression of a "mother crack" and the failure of usual mechanisms to bridge or deflect the crack. Research in AFF mechanisms has been focused at the organ level, describing the clinical presentation and radiologic appearance Although today we have not yet connected all the dots in the pathophysiology of BP-induced AFF, recent advances in measuring bone mechanical qualities at the submicroscopic and tissue levels allow us to explain how spontaneous catastrophic failure of the femur can occur. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:495 / 500
页数:6
相关论文
共 32 条
[1]
Evolution of bisphosphonate-related atypical fracture retrospectively observed with DXA scanning [J].
Ahlman, Mark A. ;
Rissing, Michael S. ;
Gordon, Leonie .
JOURNAL OF BONE AND MINERAL RESEARCH, 2012, 27 (02) :496-498
[2]
Alendronate reduces bone toughness of ribs without significantly increasing microdamage accumulation in dogs following 3 years of daily treatment [J].
Allen, Matthew R. ;
Reinwald, Susan ;
Burr, David B. .
CALCIFIED TISSUE INTERNATIONAL, 2008, 82 (05) :354-360
[3]
Bone Micromechanical Properties Are Compromised During Long-Term Alendronate Therapy Independently of Mineralization [J].
Bala, Yohann ;
Depalle, Baptiste ;
Farlay, Delphine ;
Douillard, Thierry ;
Meille, Sylvain ;
Follet, Helene ;
Chapurlat, Roland ;
Chevalier, Jerome ;
Boivin, Georges .
JOURNAL OF BONE AND MINERAL RESEARCH, 2012, 27 (04) :825-834
[4]
Effects of continuing or stopping alendronate after 5 years of treatment - The Fracture Intervention Trial long-term extension (FLEX): A randomized trial [J].
Black, Dennis M. ;
Schwartz, Ann V. ;
Ensrud, Kristine E. ;
Cauley, Jane A. ;
Levis, Silvina ;
Quandt, Sara A. ;
Satterfield, Suzanne ;
Wallace, Robert B. ;
Bauer, Douglas C. ;
Palermo, Lisa ;
Wehren, Lois E. ;
Lombardi, Antonio ;
Santora, Arthur C. ;
Cummings, Steven R. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (24) :2927-2938
[5]
Alendronate and estrogen effects in postmenopausal women with low bone mineral density [J].
Bone, HG ;
Greenspan, SL ;
McKeever, C ;
Bell, N ;
Davidson, M ;
Downs, RW ;
Emkey, R ;
Meunier, PJ ;
Miller, SS ;
Mulloy, AL ;
Recker, RR ;
Weiss, SR ;
Heyden, N ;
Musliner, T ;
Suryawanshi, S ;
Yates, AJ ;
Lombardi, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (02) :720-726
[6]
Spectroscopic markers of bone quality in alendronate-treated postmenopausal women [J].
Boskey, A. L. ;
Spevak, L. ;
Weinstein, R. S. .
OSTEOPOROSIS INTERNATIONAL, 2009, 20 (05) :793-800
[7]
Microcrack frequency and bone remodeling in postmenopausal osteoporotic women on long-term bisphosphonates: A bone biopsy study [J].
Chapurlat, Roland D. ;
Arlot, Monique ;
Burt-Pichat, Brigitte ;
Chavassieux, Pascale ;
Roux, Jean Paul ;
Portero-Muzy, Nathalie ;
Delmas, Pierre D. .
JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 (10) :1502-1509
[8]
Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis [J].
Chavassieux, PM ;
Arlot, ME ;
Reda, C ;
Wei, L ;
Yates, AJ ;
Meunier, PJ .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (06) :1475-1480
[9]
Incidence of Atypical Nontraumatic Diaphyseal Fractures of the Femur [J].
Dell, Richard M. ;
Adams, Annette L. ;
Greene, Denise F. ;
Funahashi, Tadashi T. ;
Silverman, Stuart L. ;
Eisemon, Eric O. ;
Zhou, Hui ;
Burchette, Raoul J. ;
Ott, Susan M. .
JOURNAL OF BONE AND MINERAL RESEARCH, 2012, 27 (12) :2544-2550
[10]
Reduced cortical bone compositional heterogeneity with bisphosphonate treatment in postmenopausal women with intertrochanteric and subtrochanteric fractures [J].
Donnelly, Eve ;
Meredith, Dennis S. ;
Nguyen, Joseph T. ;
Gladnick, Brian P. ;
Rebolledo, Brian J. ;
Shaffer, Andre D. ;
Lorich, Dean G. ;
Lane, Joseph M. ;
Boskey, Adele L. .
JOURNAL OF BONE AND MINERAL RESEARCH, 2012, 27 (03) :672-678